Back to Search
Start Over
EyePoint announces permanent J-Code for intracameral steroid
- Source :
- Ophthalmology Times. November 1, 2018, Vol. 43 Issue 18, 24
- Publication Year :
- 2018
-
Abstract
- EYEPOINT Pharmaceuticals announced the Centers for Medicare and Medicaid Services (CMS) has assigned a specific/permanent reimbursement J-code for dexamethasone intraocular suspension 9% (DEXYCU), the first and only FDA-approved, single-dose, sustained-release, [...]
Details
- Language :
- English
- ISSN :
- 0193032X
- Volume :
- 43
- Issue :
- 18
- Database :
- Gale General OneFile
- Journal :
- Ophthalmology Times
- Publication Type :
- Periodical
- Accession number :
- edsgcl.568370742